These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1097611)

  • 1. Carisoprodol in the treatment of myofascial pain-dysfunction syndrome.
    Gallardo F; Molgo J; Miyazaki C; Rossi E
    J Oral Surg; 1975 Sep; 33(9):655-8. PubMed ID: 1097611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome.
    Hindle TH
    Calif Med; 1972 Aug; 117(2):7-11. PubMed ID: 4262210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative study of carisoprodol, propoxyphene, and placebo in the management of low back syndrome.
    Baratta RR
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):233-40. PubMed ID: 134877
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of Parafon Forte tablets and soma compound in the treatment of painful skeletal muscle conditions.
    Miller AR
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):444-50. PubMed ID: 816602
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of changes in the pain threshold following oral administration of carisoprodol, acetylsalicylic acid, and placebo. A trial on volunteers.
    Dahl E; Grenthe B; Lindqvist B
    Swed Dent J; 1981; 5(2):77-80. PubMed ID: 7022732
    [No Abstract]   [Full Text] [Related]  

  • 7. Comorbidity between myofascial pain of the masticatory muscles and fibromyalgia.
    Dao TT; Reynolds WJ; Tenenbaum HC
    J Orofac Pain; 1997; 11(3):232-41. PubMed ID: 9610313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with Scutamil C in locomotor system disorders].
    Bednarík J; Pracke T; Pĕgrrímová E; Vykydal M
    Fysiatr Revmatol Vestn; 1972 Dec; 50(6):339-42. PubMed ID: 4565253
    [No Abstract]   [Full Text] [Related]  

  • 9. Orofacial manifestations of myofascial pain dysfunction syndrome amongst dental patients.
    Dayal PK; Desai KI; Shah TN
    Indian J Dent Res; 1990; 2(1):145-52. PubMed ID: 2096959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-reflexotherapy for the management of myofascial temporomandibular joint pain: a double-blind, placebo-controlled, randomized clinical trial.
    Berguer A; Kovacs F; Abraira V; Mufraggi N; Royuela A; Muriel A; Gestoso M; Falahat F; Martín-Granizo R; Zamora J
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1664-77. PubMed ID: 18634956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind evaluation of Parafon Forte in the treatment of musculo-skeletal back conditions.
    Vernon WG
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):801-6. PubMed ID: 4629819
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with the muscle relaxant Scutamil-C.
    Kolesár J; Durianová J
    Ther Hung; 1973; 21(3-4):121-4. PubMed ID: 4806420
    [No Abstract]   [Full Text] [Related]  

  • 13. A clinical evaluation of nefopam hydrochloride (Acupan): a new analgesic.
    Workmon FC; Winter L
    Curr Ther Res Clin Exp; 1974 Jun; 16(6):609-16. PubMed ID: 4211141
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic myofascial pain-dysfunction syndrome with chest pain.
    Rosenthal RL
    J Prosthet Dent; 1975 Oct; 34(4):444-7. PubMed ID: 1058314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diflunisal versus placebo for treatment of pain in general practice.
    Ankri J; Ageorges P; Soubrie C; Puech A; Simon P; Chastang JF; Lancrenon S; Fermanian J
    Clin Ther; 1982; 5(1):85-92. PubMed ID: 6751537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of TMJ and other facial pains: a critical review.
    Marbach JJ; Varoscak JR
    N Y State Dent J; 1980 Apr; 46(4):181-8. PubMed ID: 6987577
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of tizanidine hydrochloride in the treatment of myofascial face pain.
    Manfredini D; Romagnoli M; Cantini E; Bosco M
    Minerva Med; 2004 Apr; 95(2):165-71. PubMed ID: 15272252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pain and quality of life in bruxers and patients with myofascial pain of the masticatory muscles.
    Dao TT; Lund JP; Lavigne GJ
    J Orofac Pain; 1994; 8(4):350-6. PubMed ID: 7670422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of intramuscular phenyramidol and placebo in acute musculoskeletal pain syndromes.
    Siegler PE; Fabiani JA; Nodine JH
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):6-9. PubMed ID: 4963024
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.